A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Oral Azithromycin (500 Mg OD) as a Supplement to Standard Care for Adult Patients With Acute Exacerbations of Asthma.
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Azithromycin (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms AZALEA
- 19 Sep 2016 Results published in the JAMA Internal Medicine (2016).
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society
- 22 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.